Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Inner ear disorder, Muscle disorder, Muscle mass, Muscular weakness, SARS-CoV-2 test
Clinical narrative: Trigger jChildhood Asthma; Loss of Muscle Control and Mass; Loss of Muscle Control and Mass; Brain Fog; Fatigue; constant balance and inner ear; Fatigue and constant balance and inner ear; sleeps 18 hours day; Memory loss; Blurred Vision; Weakness in Extremities; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date Aug2021 (Lot number: FA7984) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Childhood Asthma" (unspecified if ongoing). There were no concomitant medications. The following information was reported: ASTHMA (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Trigger jChildhood Asthma"; MUSCLE DISORDER (non-serious), MUSCLE MASS (non-serious) all with onset 10Aug2021, outcome "not recovered" and all described as "Loss of Muscle Control and Mass"; FEELING ABNORMAL (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Brain Fog"; FATIGUE (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Fatigue"; BALANCE DISORDER (non-serious) with onset 10Aug2021, outcome "not recovered", described as "constant balance and inner ear"; INNER EAR DISORDER (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Fatigue and constant balance and inner ear"; SOMNOLENCE (non-serious) with onset 10Aug2021, outcome "not recovered", described as "sleeps 18 hours day"; AMNESIA (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Memory loss"; VISION BLURRED (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Blurred Vision"; MUSCULAR WEAKNESS (non-serious) with onset 10Aug2021, outcome "not recovered", described as "Weakness in Extremities". The events "trigger jchildhood asthma", "loss of muscle control and mass", "loss of muscle control and mass", "brain fog", "fatigue", "constant balance and inner ear", "fatigue and constant balance and inner ear", "sleeps 18 hours day", "memory loss", "blurred vision" and "weakness in extremities" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of asthma, muscle disorder, muscle mass, feeling abnormal, fatigue, balance disorder, inner ear disorder, somnolence, amnesia, vision blurred, muscular weakness.  Additional Information: Vaccine administration time was reported as 04:00 PM. Prior vaccination within 4 weeks and other medications in two weeks was reported as none. The patient did not had COVID prior vaccination. Patient did not have covid prior vaccination and has been tested for covid post vaccination. Facility type Vaccine was reported as pharmacy or drug store. AE resulted in: doctor or other healthcare professional office/clinic visit.  No follow-up attempts are possible. No further information is expected.